Peter Lurie is president and executive director of the Center for Science in the Public Interest. Previously, Lurie was associate commissioner for public health strategy and analysis at the FDA, working on antimicrobial resistance, drug shortages, agency transparency, caffeinated beverages, arsenic in rice, expanded access to investigational drugs, and prescription drug abuse. Prior to that, he was deputy director of Public Citizen’s Health Research Group, where he addressed drug and device issues, coauthored the organization’s Worst Pills, Best Pills consumer guide to medications, and led efforts to reduce worker exposure to hexavalent chromium and beryllium. As a faculty member at the University of California, San Francisco, and the University of Michigan, he studied needle exchange programs, ethical aspects of mother-to-infant HIV transmission studies, and other HIV policy issues.
Previously
During the COVID-19 pandemic, the Atlantic lambasted the US Food and Drug Administration for moving too slowly to approve vaccines with the provocative headline “The Death Tol...